Vol 8, No 3 (June 2019): Hepatobiliary Surgery and Nutrition (Special Focus on Antibodies and Liver Transplantation: Part 3)

Original Article

Influence of the body mass index on postoperative outcome and long-term survival after pancreatic resections in patients with underlying malignancy
Philippa Seika, Fritz Klein, Uwe Pelzer, Johann Pratschke, Marcus Bahra, Thomas Malinka
Clinical validation of scoring systems of postoperative pancreatic fistula after pancreatoduodenectomy: applicability to Eastern cohorts?
Jae Seung Kang, Taesung Park, Youngmin Han, Seungyeon Lee, Jae Ri Kim, Hongbeom Kim, Wooil Kwon, Sun-Whe Kim, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Song Cheol Kim, Tae Ho Hong, Dong Sup Yoon, Joon Seong Park, Sang Jae Park, Sung-Sik Han, Sae-Byeol Choi, Joo Seop Kim, Chang-Sup Lim, Jin-Young Jang
Neoplastic polyps in gallbladder: a retrospective study to determine risk factors and treatment strategy for gallbladder polyps
Yongliang Sun, Zhiying Yang, Xu Lan, Haidong Tan

Special Issue: Antibodies and Liver Transplantation, Guest-Edited by Prof. Vivian McAlister

The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation
Qingyong Xu, Brad Shrum, Steve Leckie, Anton Skaro, Vivian C. McAlister
Bidirectional graft-host hematological traffic in liver transplantation
Hemant Sharma, Mauro E. Tun-Abraham, Vivian McAlister


Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and its further developments in the last decade
Wan Yee Lau
Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association
Andrew A. Li, Aijaz Ahmed, Donghee Kim
Diet quality and nonalcoholic fatty liver disease
Parvin Mirmiran, Farshad Teymoori, Golaleh Asghari, Fereidoun Azizi
Robotic resection for posterosuperior liver lesions: is it really superior to laparoscopic resection?
Andrew K. Y. Fung, Kit-Fai Lee
Future is ready for swallowable sensors
Kourosh Kalantar-Zadeh, Stephanie A. Ward
Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood?
María Teresa Arias-Loste, Paula Iruzubieta, Javier Crespo
Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1)
Yifei Tan, Wei Zhang, Lunan Yan
Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality
Danielle Brandman, Norah A. Terrault
Circadian enhancer profiling in diet-induced obese mice reveals a critical time window for lipid-lowering therapies
Henrik Oster
What will happen in patients with advanced nonalcoholic fatty liver disease?
Takefumi Kimura, Naoki Tanaka, Eiji Tanaka
Adult-derived human liver stem/progenitor cells as sensors of inflammation: a potential therapy for liver disorders
Soura Mardpour, Amir Ali Hamidieh
One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade
Aditi Gupta, Sadna Budhu, Taha Merghoub
Going with the gut: probiotics as a novel therapy for hepatocellular carcinoma
Alberto Nicoletti, Maurizio Pompili, Antonio Gasbarrini, Francesca R. Ponziani
The Chengdu system for recurrent hepatocellular carcinoma: A step in the right direction
Simon Erridge, Mikael H. Sodergren
Rising trends in intrahepatic cholangiocarcinoma incidence and mortality: getting at the root cause
Mustafa Raoof, Gagandeep Singh
Robotic distal pancreatectomy: can results overcome cost-effectiveness prejudices?
Fabrizio Di Benedetto, Roberto Ballarin, Paolo Magistri
Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease
Antonio Saviano, Thomas F. Baumert